Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Vardenafil 10 mg Twice Daily to Assess the Effect on Urodynamics in Patients With Overactive Bladder (Detrusor Overactivity)

NCT00478881 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT00478881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00478881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Vardenafil 10 mg Twice Daily to Assess the Effect on Urodynamics in Patients With Overactive Bladder (Detrusor Overactivity)
Lead sponsor
Bayer
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2007
Completion date
November 30, 2008
Enrollment
397 (actual)
Sites
55

Conditions

As the registry lists them; a condition with its own page is linked.

detrusor overactivity, overactive bladder